INFLUENCE OF DISEASE ON BINDING OF DRUGS TO PLASMA-PROTEINS

[1] ANTON AH, 1971, ACTA PHARMACOL TOX, V29, P134

[2] ARANGO G, 1968, MAYO CLIN PROC, V43, P503

[3] BIGGS JT, 1971, P SOC EXP BIOL MED, V137, P692, DOI 10.3181/00379727-137-35647

[4] BLUM MR, 1972, NEW ENGL J MED, V286, P109

[5] BRIDGMAN JF, 1972, LANCET, V2, P506

[6] ZUR PHARMAKOKINETIK VON SULFONAMIDEN UNTER PATHOLOGISCHEN BEDINGUNGEN [J]. KLINISCHE WOCHENSCHRIFT, 1964, 42 (02): : 103 - &

[7] CONN HL, 1961, J PHARMACOL EXP THER, V133, P76

[8] Ehrstrom MC, 1937, ACTA MED SCAND, V91, P191

[9] GULASSAY PF, 1971, 5 ANN M AM SOC NEPHR, P29

[10] LASSEN JB, 1963, ACTA PHARMACOL TOX, V20, P309

[1] ANTON AH, 1971, ACTA PHARMACOL TOX, V29, P134

[2] ARANGO G, 1968, MAYO CLIN PROC, V43, P503

[3] BIGGS JT, 1971, P SOC EXP BIOL MED, V137, P692, DOI 10.3181/00379727-137-35647

[4] BLUM MR, 1972, NEW ENGL J MED, V286, P109

[5] BRIDGMAN JF, 1972, LANCET, V2, P506

[6] ZUR PHARMAKOKINETIK VON SULFONAMIDEN UNTER PATHOLOGISCHEN BEDINGUNGEN [J]. KLINISCHE WOCHENSCHRIFT, 1964, 42 (02): : 103 - &

[7] CONN HL, 1961, J PHARMACOL EXP THER, V133, P76

[8] Ehrstrom MC, 1937, ACTA MED SCAND, V91, P191

[9] GULASSAY PF, 1971, 5 ANN M AM SOC NEPHR, P29

[10] LASSEN JB, 1963, ACTA PHARMACOL TOX, V20, P309